7 March, 2023Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing
2 February, 2023RefleXion receives FDA clearance for SCINTIX biology-guided radiotherapy; cutting-edge treatment applicable for early and late-stage cancers
5 January, 2023Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer